COM:HEALTHEQUITY
HealthEquity
- Stock
Last Close
102.96
21/11 21:00
Market Cap
6.88B
Beta: -
Volume Today
686.31K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '14 | Jan '15 | Jan '16 | Jan '17 | Jan '18 | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | Jan '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 508K - | 622.50K 22.54% | 606K 2.65% | 403.50K 33.42% | 107.50K 73.36% | |||||||
average payables | 1.84M - | 1.87M 1.72% | 2.83M 51.37% | 2.82M 0.19% | 2.97M 5.30% | 3.75M 26.26% | 2.80M 25.41% | 14.58M 421.18% | 20.72M 42.14% | |||
average receivables | 7.38M - | 11.68M 58.29% | 15.65M 34.02% | 19.30M 23.30% | 23.64M 22.45% | 48.08M 103.41% | 71.63M 48.98% | 80.10M 11.83% | 92.13M 15.02% | |||
book value per share | 6.02 - | 4.62 23.21% | 3.59 22.38% | 4.47 24.58% | 5.74 28.49% | 7.72 34.36% | 15.37 99.24% | 18.57 20.82% | 22.28 19.99% | 22.45 0.74% | ||
capex per share | -0.96 - | -0.26 72.90% | -0.88 236.40% | -0.22 75.35% | -0.55 156.00% | -0.24 56.06% | -0.63 158.05% | -1.31 108.08% | -1.65 26.24% | -1.41 14.44% | -0.02 98.62% | |
capex to depreciation | -1.27 - | -1.38 8.39% | -5.79 319.04% | -0.96 83.39% | -2.09 117.71% | -0.83 60.47% | -0.76 8.11% | -0.84 10.06% | -1.00 19.44% | -0.74 26.04% | -0.01 98.50% | |
capex to operating cash flow | -0.30 - | -0.54 79.02% | -1.87 246.89% | -0.28 85.17% | -0.41 46.97% | -0.13 67.54% | -0.40 199.70% | -0.53 34.32% | -0.97 82.11% | -0.79 18.67% | -0.01 99.12% | |
capex to revenue | -0.09 - | -0.09 5.54% | -0.39 324.02% | -0.07 81.89% | -0.15 104.68% | -0.05 64.00% | -0.08 51.03% | -0.13 67.13% | -0.18 37.08% | -0.14 23.71% | -0.00 98.77% | |
cash per share | 2.46 - | 3.56 44.55% | 2.18 38.70% | 3.08 41.00% | 3.98 29.49% | 11.69 193.44% | 2.86 75.53% | 4.43 54.84% | 2.71 38.78% | 3.01 11.05% | ||
days of inventory on hand | 4.89 - | 5.72 17.09% | 4.18 26.99% | 3.00 28.15% | 0.83 72.36% | |||||||
days payables outstanding | 29.59 - | 11.93 59.69% | 16.37 37.31% | 16.33 0.30% | 9.34 42.81% | 12.12 29.76% | 7.05 41.82% | 1.85 73.74% | 30.20 1,531.46% | 13.65 54.80% | ||
days sales outstanding | 33.58 - | 37.62 12.03% | 41.19 9.50% | 34.79 15.54% | 34.35 1.26% | 32.62 5.05% | 48.36 48.27% | 36.21 25.13% | 42.18 16.50% | 41.02 2.76% | ||
debt to assets | 0.51 - | 0.40 21.79% | 0.32 18.20% | 0.32 0.78% | ||||||||
debt to equity | 1.26 - | 0.78 38.26% | 0.54 30.20% | 0.52 3.60% | ||||||||
dividend yield | 0.01 - | 0.08 1,014.10% | ||||||||||
earnings yield | 0.01 - | 0.02 26.62% | 0.01 12.27% | 0.01 29.35% | 0.02 59.47% | 0.02 23.56% | 0.01 53.27% | 0.00 84.16% | -0.01 802.44% | -0.01 48.96% | 0.01 266.61% | |
enterprise value | 85.54M - | 536.62M 527.33% | 1.12B 109.23% | 2.57B 128.99% | 2.85B 10.97% | 3.49B 22.44% | 5.54B 58.50% | 6.97B 25.89% | 5.23B 25.04% | 5.88B 12.50% | ||
enterprise value over ebitda | 5.46 - | 29.59 441.86% | 32.32 9.22% | 47.26 46.25% | 40.54 14.21% | 36.44 10.11% | 35.63 2.22% | 35.00 1.79% | 30.41 13.10% | 29.37 3.41% | ||
ev to operating cash flow | 4.75 - | 35.67 651.12% | 42.30 18.61% | 56.39 33.31% | 34.92 38.08% | 30.80 11.80% | 52.31 69.83% | 38.38 26.62% | 37.06 3.44% | 39.02 5.29% | ||
ev to sales | 1.38 - | 6.11 342.82% | 8.86 44.98% | 14.41 62.76% | 12.43 13.76% | 12.16 2.16% | 10.41 14.42% | 9.50 8.70% | 6.91 27.32% | 6.82 1.23% | ||
free cash flow per share | 2.23 - | 0.22 90.04% | -0.41 284.63% | 0.56 237.17% | 0.80 42.68% | 1.59 98.56% | 0.95 40.19% | 1.14 19.83% | 0.05 95.87% | 0.37 692.91% | 2.77 642.82% | |
free cash flow yield | 0.13 - | 0.01 91.56% | -0.02 280.29% | 0.01 163.08% | 0.02 30.37% | 0.03 61.23% | 0.01 43.56% | 0.01 5.59% | 0.00 93.52% | 0.01 596.35% | 0.04 498.05% | |
graham net net | -0.48 - | 3.32 796.67% | 2.09 37.03% | 3.01 43.92% | 3.88 28.91% | 11.47 195.98% | -19.25 267.83% | -12.77 33.67% | -11.59 9.23% | -10.26 11.48% | ||
graham number | 5.44 - | 5.82 7.12% | 4.86 16.49% | 6.73 38.35% | 10.07 49.76% | 14.40 42.99% | 14.31 0.67% | 7.05 50.71% | 16.34 131.77% | 12.51 23.49% | ||
income quality | 14.61 - | 1.48 89.87% | 1.60 7.94% | 1.73 8.19% | 1.73 0.20% | 1.53 11.03% | 2.67 73.89% | 20.56 670.34% | -3.18 115.48% | -5.76 81.01% | 4.36 175.64% | |
intangibles to total assets | 0.53 - | 0.20 63.11% | 0.33 65.56% | 0.25 23.26% | 0.24 4.18% | 0.17 30.87% | 0.83 399.29% | 0.77 6.40% | 0.84 9.10% | 0.84 0.73% | 0 100% | |
interest coverage | 261.91 - | -383.48 246.42% | 3.11 - | 2.39 23.20% | 0.95 60.33% | 0.80 15.13% | -2.12 364.04% | |||||
interest debt per share | 0.01 - | -0.00 118.12% | 19.78 - | 14.95 24.42% | 12.57 15.94% | 12.35 1.73% | ||||||
inventory turnover | 74.71 - | 63.81 14.59% | 87.40 36.97% | 121.65 39.18% | 440.04 261.74% | |||||||
invested capital | 1.26 - | 0.78 38.26% | 0.54 30.20% | 0.52 3.60% | ||||||||
market cap | 99.46M - | 647.63M 551.16% | 1.21B 86.28% | 2.71B 124.71% | 3.05B 12.60% | 3.85B 26.28% | 4.43B 14.86% | 6.22B 40.58% | 4.44B 28.63% | 5.14B 15.66% | 6.57B 27.91% | |
net current asset value | 2.67M - | 110.05M 4,015.37% | 126.71M 15.14% | 183.62M 44.92% | 242.51M 32.07% | 361.74M 49.16% | -1.24B 442.48% | -871.10M 29.69% | -903.19M 3.68% | -810.37M 10.28% | ||
net debt to ebitda | -0.89 - | -6.12 588.95% | -2.41 60.67% | -2.57 6.87% | -2.83 10.18% | -3.77 33.04% | 7.14 289.32% | 3.75 47.53% | 4.56 21.61% | 3.70 18.81% | ||
net income per share | 0.22 - | 0.33 49.42% | 0.29 10.16% | 0.45 53.63% | 0.79 74.54% | 1.20 52.16% | 0.59 50.48% | 0.12 79.89% | -0.53 547.69% | -0.31 41.89% | 0.64 306.94% | |
operating cash flow per share | 3.19 - | 0.48 84.86% | 0.47 3.03% | 0.78 66.22% | 1.35 74.19% | 1.83 35.38% | 1.58 13.90% | 2.45 54.91% | 1.70 30.68% | 1.78 5.19% | 2.79 56.52% | |
payables turnover | 12.34 - | 30.61 148.11% | 22.29 27.17% | 22.36 0.30% | 39.09 74.86% | 30.13 22.94% | 51.78 71.87% | 197.17 280.79% | 12.09 93.87% | 26.74 121.25% | ||
receivables turnover | 10.87 - | 9.70 10.73% | 8.86 8.68% | 10.49 18.40% | 10.63 1.27% | 11.19 5.32% | 7.55 32.55% | 10.08 33.57% | 8.65 14.16% | 8.90 2.84% | ||
research and ddevelopement to revenue | 0.12 - | 0.12 3.79% | 0.13 11.07% | 0.13 5.51% | 0.12 4.89% | 0.12 2.29% | 0.15 19.48% | 0.17 16.68% | 0.21 22.25% | 0.22 7.88% | 0.22 2.45% | |
return on tangible assets | 0.05 - | 0.08 66.40% | 0.11 40.58% | 0.13 12.41% | 0.17 33.91% | 0.17 2.95% | 0.09 48.97% | 0.01 83.82% | -0.09 732.90% | -0.05 42.88% | ||
revenue per share | 10.97 - | 2.82 74.33% | 2.24 20.66% | 3.04 36.14% | 3.81 25.08% | 4.65 22.05% | 7.94 70.87% | 9.88 24.50% | 9.10 7.91% | 10.21 12.14% | 11.50 12.64% | |
roe | 0.04 - | 0.07 94.59% | 0.08 15.74% | 0.10 23.32% | 0.14 35.83% | 0.15 13.25% | 0.04 75.15% | 0.01 83.36% | -0.02 473.11% | -0.01 42.31% | ||
roic | 0.08 - | 0.08 2.87% | 0.08 10.62% | 0.10 23.82% | 0.14 37.88% | 0.16 11.26% | 0.03 81.51% | 0.07 138.22% | 0.01 88.81% | 0.01 15.39% | ||
sales general and administrative to revenue | 0.06 - | 0.09 51.12% | 0.11 17.22% | 0.11 1.49% | 0.11 3.16% | 0.12 5.13% | 0.11 1.03% | 0.12 1.18% | 0.11 3.17% | 0.11 0.50% | 0.10 6.55% | |
shareholders equity per share | 6.02 - | 4.62 23.21% | 3.59 22.38% | 4.47 24.58% | 5.74 28.49% | 7.72 34.36% | 15.37 99.24% | 18.57 20.82% | 22.28 19.99% | 22.45 0.74% | ||
stock based compensation to revenue | 0.00 - | 0.03 3,026.92% | 0.05 61.45% | 0.05 1.47% | 0.06 32.42% | 0.07 17.58% | 0.07 2.17% | 0.06 21.98% | 0.07 19.33% | 0.07 4.21% | 0.08 6.23% | |
tangible asset value | 4.67M - | 112.90M 2,319.70% | 131.97M 16.88% | 192.27M 45.70% | 257.99M 34.18% | 392.76M 52.24% | -1.09B 376.79% | -715.07M 34.22% | -766.40M 7.18% | -688.86M 10.12% | ||
tangible book value per share | 0.83 - | 3.62 338.53% | 2.33 35.74% | 3.28 40.98% | 4.28 30.42% | 6.35 48.47% | -16.22 355.35% | -9.63 40.61% | -9.22 4.29% | -8.16 11.51% | ||
working capital | 14.33M - | 115.89M 708.88% | 130.94M 12.99% | 185.12M 41.37% | 244.91M 32.30% | 365.62M 49.29% | 143.87M 60.65% | 255.88M 77.86% | 198.15M 22.56% | 251.83M 27.09% |
All numbers in (except ratios and percentages)